OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma
Jingjing Yu, Peng Zhu, Linlin Shi, et al.
Cell Host & Microbe (2023) Vol. 32, Iss. 1, pp. 131-144.e6
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4

Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 8

Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access

The crucial function of gut microbiota on gut-liver repair
Yamei Wang, Yan He, Qianqian Zheng, et al.
hLife (2025)
Open Access

MoS2 Nanozyme–Chlorella Hydrogels: Pioneering a Hepatocellular Carcinoma Integrative Therapy
Mengya Zhang, Jingsheng Zhou, Xianghe Jiang, et al.
Advanced Functional Materials (2025)
Closed Access

Perioperative Multi-Kingdom Gut Microbiota Alters in Coronary Artery Bypass Grafting
Zhou Fu, Yanxiong Jia, Jing Zhao, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 475-475
Open Access

HCC and Immunotherapy: The Potential Predictive Role of Gut Microbiota and Future Therapeutic Strategies
Carmelo Laface, E Lauricella, Girolamo Ranieri, et al.
Onco (2025) Vol. 5, Iss. 1, pp. 9-9
Open Access

REGγ Mitigates Radiation-Induced Enteritis by Preserving Mucin Secretion and Sustaining Microbiome Homeostasis
Xiangzhan Zhu, Ya Li, Xue Tian, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 6, pp. 975-988
Closed Access | Times Cited: 3

Genetically predicted immune cells mediate the association between gut microbiota and neuropathy pain
Zhixuan Lan, Yi Wei, Kan Yue, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3357-3373
Open Access | Times Cited: 3

Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma
Ping Chen, Chengchen Yang, Rende Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

High molecular weight polysaccharides from Ganoderma lucidum attenuates inflammatory responses, gut microbiota, and liver metabolomic in lipopolysaccharide-induced liver injury mice
Weiling Guo, Wenli Liu, Liang Peng, et al.
International Journal of Biological Macromolecules (2024), pp. 138400-138400
Closed Access | Times Cited: 3

Postoperative delayed gastric emptying: may gut microbiota play a role?
Zhiyi Wang, Chuanbo Liu, Kaiwen Hu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2

Analysis of gut microecological characteristics and differences between children with biliary atresia and non-biliary atresia in infantile cholestasis
Yajun Liu, Yuan Zhang, Cheng Guo, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1

Probiotics alleviate paraneoplastic thrombocythemia of ovarian cancer: A randomized placebo-controlled trial
Xiaoni Zhou, Gang Hu, Zhaowei Luo, et al.
Journal of Functional Foods (2024) Vol. 119, pp. 106316-106316
Open Access | Times Cited: 1

Therapeutic manipulation of the microbiome in liver disease
Gopanandan Parthasarathy, Harmeet Malhi, Jasmohan S. Bajaj
Hepatology (2024)
Closed Access | Times Cited: 1

Decoding the microbiota metabolome in hepatobiliary and pancreatic cancers: Pathways to precision diagnostics and targeted therapeutics
Yuemiao Xu, Jiahan Le, Jiang‐Jiang Qin, et al.
Pharmacological Research (2024) Vol. 208, pp. 107364-107364
Open Access | Times Cited: 1

Design of probiotic delivery systems and their therapeutic effects on targeted tissues
Cong Xu, Jiahui Guo, Baoyue Chang, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 20-46
Closed Access | Times Cited: 1

Bie Jia Jian pill ameliorates BDL-induced cholestatic hepatic fibrosis in rats by regulating intestinal microbial composition and TMAO-mediated PI3K/AKT signaling pathway
Xiaoyan Cui, Ronghua Zhang, Y Q Li, et al.
Journal of Ethnopharmacology (2024), pp. 118910-118910
Closed Access | Times Cited: 1

Targeting the gut and tumor microbiome in cancer resistance
Sona Ciernikova, Aneta Sevcikova, Michal Mego
AJP Cell Physiology (2024) Vol. 327, Iss. 6, pp. C1433-C1450
Closed Access | Times Cited: 1

Origin of the neonatal gut microbiota and probiotic intervention: a randomized controlled trial
Zhe Li, Yiwen Zhang, Xiaozhi Tan, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access

Gut microbiome and liver diseases
Jun Xu, Ning Chen, Li Zhou, et al.
Fundamental Research (2024)
Open Access

Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
Chenyang Li, Chujun Cai, Chendong Wang, et al.
Clinical and Molecular Hepatology (2024)
Open Access

Page 1 - Next Page

Scroll to top